Meglumine Adenosine Cyclophosphate

环磷腺苷葡胺

Report date: 2022/09/06 16:01:46
NME

Base Information

Drug NameMeglumine Adenosine Cyclophosphate
Drug Alias NameMeglumine cyclic adenosine phosphate葡甲胺腺苷环磷酸
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsCoronary DiseaseHeart FailureMyocarditis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsCoronary DiseaseHeart FailureMyocarditis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeC01
Related LinksN/A